This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mindray Medical International Ltd (MR)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 198.99M 230.55M 180.21M 166.63M
Operating Gains/Losses 77.00K -91.00K 2.11M -1.57M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 3.42M -22.79M -2.83M -51.10M
(Increase) Decrease in Inventories -14.64M -18.98M -11.18M -15.19M
(Increase) Decrease In Other Current Assets 0.00 0.00 -1.11M 0.00
(Decrease) Increase In Payables -504.00K 27.66M 48.88M 5.47M
(Decrease) Increase In Other Current Liabilities 17.34M -6.43M 10.42M 12.72M
(Increase) Decrease In Other Working Capital 28.75M 28.70M 29.49M 26.08M
Other Non-Cash Items 23.50M 15.90M 27.31M 14.84M
Net Cash From Continuing Operations 330.45M 307.92M 325.67M 192.40M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 330.45M 307.92M 325.67M 192.40M
Sale of Property, Plant & Equipment 981.00K 741.00K 1.77M 4.53M
Cash Used for Investing Activities
Sale of Short-Term Investments 825.84M 652.90M 144.40M 100.27M
Purchases of Property, Plant & Equipment -107.12M -109.08M -65.60M -76.24M
Acquisitions -11.76M -109.38M -34.55M -6.53M
Purchases of Short-Term Investments -805.14M -863.04M -257.02M -264.12M
Other Cash from Investing Activities 4.37M 3.32M -21.53M -16.19M
Cash Provided by Financing Activities
Net Cash From Investing Activities -92.84M -424.54M -232.54M -258.28M
Issuance of Debt 0.00 0.00 52.00M 85.40M
Cash Used for Financing Activities
Issuance of Capital Stock 3.32M 16.09M 24.59M 7.12M
Repayment of Long-Term Debt -214.38M -35.00M -2.48M 0.00
Repurchase of Capital Stock -68.08M -42.37M 0.00 -10.16M
Payment of Cash Dividends -64.52M -59.07M -46.40M -34.52M
Other Financing Charges, Net 655.00K 371.72M 506.00K 797.00K
Net Cash From Financing Activities -343.00M 251.37M 28.22M 48.64M
Effect of Exchange Rate Changes -3.24M 2.62M 2.20M 4.05M
Net Change in Cash & Cash Equivalents -108.63M 137.36M 123.55M -13.19M
MR News

MR Mindray Medical International Ltd

Chart of MR

Analysts Ratings for MR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

MR Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs